• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中间型β地中海贫血和重型β地中海贫血临床无症状患者的心功能与心律失常比较

A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.

作者信息

Amoozgar Hamid, Zeighami Samaneh, Haghpanah Sezaneh, Karimi Mehran

机构信息

a Neonatology and Cardiovascular Research Center , Shiraz University of Medical Sciences , Shiraz , Iran.

b Department of Pediatrics, School of Medicine , Shiraz University of Medical Sciences , Shiraz , Iran.

出版信息

Hematology. 2017 Jan;22(1):25-29. doi: 10.1080/10245332.2016.1226699. Epub 2016 Sep 20.

DOI:10.1080/10245332.2016.1226699
PMID:27650671
Abstract

BACKGROUND

The goal of this study was to compare heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.

METHOD

In this cross-sectional study, 60 patients with beta thalassemia major and 60 patients with beta thalassemia intermedia who had clinically no symptoms of arrhythmia and clinically normal heart function were evaluated using 24-hour ambulatory electrocardiogram monitoring and echocardiography. For data analysis SPSS ver.20 software was used. A P-value of less than 0.05 was considered statistically significant.

RESULTS

The mean age of the beta thalassemia intermedia patients was 24.18 ± 7.9 years and the mean age in beta thalassemia major was 24.38 ± 7.7 years (P>0.05). Premature atrial contractions (PACs) were observed in 14 (23.3%) patients with beta thalassemia intermedia and in 22 (36.6%) beta thalassemia major patients. Premature ventricular contractions (PVCs) were detected in 8 (13.3%) patients in the beta thalassemia intermediate group and 16 (26.6) patients in the beta thalassemia major group, respectively. The left ventricular diastolic dimension, end-diastolic volume, and stroke volume were significantly higher in beta thalassemia intermedia group (P<0.05). Pulmonary acceleration time as an indicator of pulmonary pressure was lower in beta thalassemia intermedia group.

CONCLUSION

Both atrial and ventricular arrhythmias were more common in the beta thalassemia major group. Higher end-diastolic volume and stroke volume were detected in the beta thalassemia intermedia group. Pulmonary acceleration time was lower in the beta thalassemia intermedia group, which can be an indicator of higher pulmonary pressure.

摘要

背景

本研究的目的是比较中间型β地中海贫血和重型β地中海贫血临床无症状患者的心脏功能和心律失常情况。

方法

在这项横断面研究中,对60例重型β地中海贫血患者和60例中间型β地中海贫血患者进行了评估,这些患者临床上没有心律失常症状且心脏功能正常,采用24小时动态心电图监测和超声心动图检查。数据分析使用SPSS 20.0软件。P值小于0.05被认为具有统计学意义。

结果

中间型β地中海贫血患者的平均年龄为24.18±7.9岁,重型β地中海贫血患者的平均年龄为24.38±7.7岁(P>0.05)。14例(23.3%)中间型β地中海贫血患者和22例(36.6%)重型β地中海贫血患者出现房性早搏(PACs)。中间型β地中海贫血组8例(13.3%)患者和重型β地中海贫血组16例(26.6%)患者分别检测到室性早搏(PVCs)。中间型β地中海贫血组的左心室舒张末期内径、舒张末期容积和每搏输出量显著更高(P<0.05)。作为肺压力指标的肺动脉加速时间在中间型β地中海贫血组较低。

结论

重型β地中海贫血组房性和室性心律失常更为常见。中间型β地中海贫血组检测到更高的舒张末期容积和每搏输出量。中间型β地中海贫血组的肺动脉加速时间较低,这可能是肺压力较高的一个指标。

相似文献

1
A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major.中间型β地中海贫血和重型β地中海贫血临床无症状患者的心功能与心律失常比较
Hematology. 2017 Jan;22(1):25-29. doi: 10.1080/10245332.2016.1226699. Epub 2016 Sep 20.
2
Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.中间型和重型β地中海贫血的超声心动图表现:中间型β地中海贫血患者经羟基脲治疗后无肺动脉高压
Eur J Haematol. 2009 Mar;82(3):213-8. doi: 10.1111/j.1600-0609.2008.01192.x. Epub 2008 Dec 5.
3
Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.无创评估在预测多次输血的重型地中海贫血患者临床前期心脏病变中的作用
Hematology. 2014 Oct;19(7):380-7. doi: 10.1179/1607845413Y.0000000140. Epub 2013 Nov 12.
4
Early Cardiac Involvement and Risk Factors for the Development of Arrhythmia in Patients With β-Thalassemia Major.重型β地中海贫血患者的早期心脏受累及心律失常发生的危险因素
J Pediatr Hematol Oncol. 2016 Jan;38(1):5-11. doi: 10.1097/MPH.0000000000000467.
5
Comparative study of pulmonary circulation and myocardial function in patients with β-thalassemia intermedia with and without hydroxyurea, a case-control study.β-中间型地中海贫血患者使用和不使用羟基脲的肺循环和心肌功能的对比研究:一项病例对照研究。
Eur J Haematol. 2011 Jul;87(1):61-7. doi: 10.1111/j.1600-0609.2011.01620.x.
6
The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic dysfunction in β-thalassemia major.β-地中海贫血症患者左房功能与左室舒张功能障碍的病理生理关系及其临床意义。
Am J Hematol. 2014 Jan;89(1):13-8. doi: 10.1002/ajh.23581. Epub 2013 Sep 19.
7
Left ventricular remodeling, systolic function, and diastolic function in young adults with beta-thalassemia intermedia: a Doppler echocardiography study.中间型β地中海贫血年轻成人的左心室重构、收缩功能和舒张功能:一项多普勒超声心动图研究
Chest. 2002 Feb;121(2):506-12. doi: 10.1378/chest.121.2.506.
8
Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.地中海贫血性心脏病:重型与中间型地中海贫血的比较评估
Chest. 2005 May;127(5):1523-30. doi: 10.1378/chest.127.5.1523.
9
Cardiac involvement in beta-thalassemia major and beta-thalassemia intermedia.重型β地中海贫血和中间型β地中海贫血的心脏受累情况。
Hemoglobin. 2004 May;28(2):123-9. doi: 10.1081/hem-120034248.
10
Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia.中间型β地中海贫血患者的肺动脉高压和右心衰竭
Chest. 1995 Jan;107(1):50-3. doi: 10.1378/chest.107.1.50.

引用本文的文献

1
Diagnostic Modalities in Detecting Cardiovascular Complications of Thalassemia.地中海贫血心血管并发症检测中的诊断方法
Rev Cardiovasc Med. 2022 Jul 22;23(8):267. doi: 10.31083/j.rcm2308267. eCollection 2022 Aug.
2
Subclinical Left Ventricular Dysfunction in Children and Adolescence With Thalassemia Intermedia.中间型地中海贫血患儿及青少年的亚临床左心室功能障碍
Front Pediatr. 2022 Jun 17;10:774528. doi: 10.3389/fped.2022.774528. eCollection 2022.
3
Atrial Fibrillation in β-Thalassemia: Overview of Mechanism, Significance and Clinical Management.
β地中海贫血中的心房颤动:机制、意义及临床管理概述
Biology (Basel). 2022 Jan 17;11(1):148. doi: 10.3390/biology11010148.
4
Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.非输血依赖型地中海贫血:并发症与治疗的最新进展。
Int J Mol Sci. 2018 Jan 8;19(1):182. doi: 10.3390/ijms19010182.